Published on September 7, 2013 at 6:48 AM
The data reveal that for most companies, these relationships make up a small percentage of the total KOL pool that MSLs target for building relationships. Interestingly, US companies are less likely to have relationships with KOLs on these panels than in Canada or Europe. This is likely because many of those countries have more restrictive reimbursement policies.
"MSL Activities and Performance Measurement: Harnessing KOL Relationships for Optimal Clinical Support" (http://www.cuttingedgeinfo.com/research/medical-affairs/msl-medical-science-liaisons/) explores the best practices of top-performing medical science liaison teams at companies in the US, Europe, Canada and the Asia Pacific region. This report is designed to help medical affairs departments and MSL teams:
Empower MSLs to coordinate with internal functions, including medical and clinical teams and commercial groups.
Prioritize thought leader criteria and build strong KOL relationships.
Implement best practices for using quantitative and qualitative data to showcase MSL value to stakeholders.
SOURCE Cutting Edge Information